Study of Teverelix DP on Prostate Volume, Urinary Function and Clinical Outcomes Following Acute Urinary Retention

Clinical trial NCT07733934 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07733934
Sponsor: Antev Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Urinary Retention Benign Prostate Hypertrophy(BPH)

Start date: 2026-09-01
Primary completion: 2028-05-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.